Caregiver Preference Data Shape Clinical Performance Goals for a Pediatric Ear Tube Device
Source
Value & Outcomes Spotlight
Link
Using Patient Preference Information in Medical Device Regulatory Decisions: Benefit-Risk and Beyond
Description of Case Study
Smith+Nephew, a medtech company developing a first-of-a-kind tympanostomy tube (ear tube) combination drug-device product, conducted a patient preference study with parents of children who may require ear tube placement. The company used the patient preference information to help them understand the trade-offs that parents are willing to make when considering a more convenient office-based procedure performed under local anesthesia with a potentially lower success rate compared with traditional ear tube placement under general anesthesia in the operating room. The company used surveys and other methods to capture caregiver perspectives on treatment benefits, risks, and device-related attributes and to inform product development and regulatory decision-making.
Quick Facts Organization name: Smith+Nephew |
Product Type(s)
medical devices:
- implantable device
- home-use device
- therapeutic device
Product Medical Specialty Area(s)
- ear, nose, throat
Stakeholders
- medtech company: internal discovery/research and development teams
- patients and caregivers, patient organizations
Methods and Sources of Patient Input
- interviews/focus groups/surveys
- patient preference information/studies
Impact of Patient Engagement
The patient preference study provided quantitative evidence about the trade-offs that caregivers were willing to make when evaluating treatment options for children requiring tympanostomy tubes and related ear interventions. By capturing which benefits, risks, and treatment characteristics were most important to families, the study demonstrated how patient preference information can complement traditional clinical evidence and can support product development and regulatory benefit-risk assessments. Ultimately, these preference study findings informed the effectiveness performance goal of a clinical study.
Lessons Learned
Stakeholders highlighted four key lessons following the completion of this patient preference study:
- Target outreach within the US Food and Drug Administration (FDA): To maximize efficiency, it is important to discuss studies with the appropriate experts at the FDA to avoid wasting limited time.
- Apply rigor to patient preference research: When conducting a patient preference study, it should be treated like a clinical study and include elements such as a budget, timeline, and statistical rigor.
- Leverage external expertise when needed: If a company lacks the proper expertise internally, it should identify the appropriate external partners to collaborate with.
- Engage the FDA early to align expectations: It is most beneficial to engage with the FDA early in the process, especially for companies with limited financial resources and time.